Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma.

Antonio SilvaniIrene De SimoneVittorio FregoniElena BiagioliEnrico MarchioniManuela CaroliAndrea SalmaggiAndrea PaceValter TorriPaola GavianiErica QuaquariniGiorgia SimonettiEliana RulliMaurizio D'Incalcinull null

Published in: Journal of neuro-oncology (2019)

This study is registered with ClinicalTrials.gov, number NCT01989884.

Keyphrases

open label
cross sectional
clinical trial